News & Updates

Show Multimedia Only

ICLAD predicts poor vascular outcomes after ischaemic stroke

16 Apr 2026 by

The presence of intracranial large artery disease (ICLAD) is associated with poor composite vascular outcomes, myocardial infarction (MI), and vascular death, but not recurrence, in patients with acute ischaemic stroke, suggests a Singapore study.

ICLAD predicts poor vascular outcomes after ischaemic stroke

16 Apr 2026

Low micronutrients worsen effects of blood heavy metals on cognitive function

15 Apr 2026

Blood concentrations of heavy metals tend to induce cognitive decline, especially among individuals with lower micronutrient status, reveals a study.

Low micronutrients worsen effects of blood heavy metals on cognitive function

15 Apr 2026

Adjunctive soticlestat minimally beneficial in Lennox–Gastaut syndrome

14 Apr 2026

Use of the cholesterol 24-hydroxylase inhibitor soticlestat as adjunctive therapy in patients with Lennox–Gastaut syndrome (LGS) falls short of reducing the frequency of major motor drop (MMD) seizures, according to the results of the phase III SKYWAY trial.

Adjunctive soticlestat minimally beneficial in Lennox–Gastaut syndrome

14 Apr 2026

FA-fortified iodized salt improves folate status of nonpregnant women

10 Apr 2026

Folic acid (FA) fortification of iodized salt results in improvements in women’s folate status, which then lowers the risk of neural tube defect (NTD)-affected pregnancies, a study has shown.

FA-fortified iodized salt improves folate status of nonpregnant women

10 Apr 2026

Meta-analysis: Plant-based foods, fish serve up cognitive benefits for the Chinese

09 Apr 2026 by

Eating vegetables, fruits, fish, and plant-based foods helps enhance brain function and lower the risk of cognitive impairment and decline in Chinese populations, including those from mainland China, Hong Kong, Taiwan, and Singapore, according to a systematic review and meta-analysis.

Meta-analysis: Plant-based foods, fish serve up cognitive benefits for the Chinese

09 Apr 2026

Wearable red-light device looks good for poststroke rehabilitation

08 Apr 2026 by

A novel wearable red-light device for photobiomodulation of the brain shows promise for poststroke rehabilitation, with favourable effects on cognitive function and neuropsychiatric symptoms, as shown in a study.

Wearable red-light device looks good for poststroke rehabilitation

08 Apr 2026

Tavapadon shows promise as adjunct therapy for Parkinson’s Disease in phase III trial

08 Apr 2026 by

Tavapadon, a novel, investigational, selective D1/D5 agonist with once-daily oral dosing, provides clinically meaningful and sustained benefit adjunctive to levodopa and has a favourable safety profile in patients with Parkinson’s disease (PD) experiencing off fluctuations, according to findings of the TEMPO-3 trial.

Tavapadon shows promise as adjunct therapy for Parkinson’s Disease in phase III trial

08 Apr 2026

Increased ischaemic stroke cases during Ramadan

08 Apr 2026 by

A study conducted in southern Thailand has found a higher incidence of non-recurrent ischaemic stroke among Muslims during the Ramadan period (when Muslims observe a ‘fasting window’ from sunrise to sunset) compared with the rest of the year.

Increased ischaemic stroke cases during Ramadan

08 Apr 2026

CardiOmicScore: AI tool for personalized long-term CV risk prediction with enhanced accuracy

07 Apr 2026 by

Researchers from the University of Hong Kong (HKU) have developed an innovative AI-based tool that can predict, with enhanced accuracy, the risk of six most common cardiovascular diseases (CVDs) up to 15 years prior to disease onset when combined with clinical data.

CardiOmicScore: AI tool for personalized long-term CV risk prediction with enhanced accuracy

07 Apr 2026

Which strategy is best for treating hepatic encephalopathy in patients with dementia?

06 Apr 2026

In the management of hepatic encephalopathy among patients diagnosed with dementia, the combination of Fibrosis-4 (FIB-4) screening, hepatology referral, and lactulose therapy provides balance in terms of value and clinical benefit, suggests a study.

Which strategy is best for treating hepatic encephalopathy in patients with dementia?

06 Apr 2026

News & Updates

Showing Neurology articles

Showing

Specialty:

ICLAD predicts poor vascular outcomes after ischaemic stroke

ICLAD predicts poor vascular outcomes after ischaemic stroke

Low micronutrients worsen effects of blood heavy metals on cognitive function

Low micronutrients worsen effects of blood heavy metals on cognitive function

Adjunctive soticlestat minimally beneficial in Lennox–Gastaut syndrome

Adjunctive soticlestat minimally beneficial in Lennox–Gastaut syndrome

FA-fortified iodized salt improves folate status of nonpregnant women

FA-fortified iodized salt improves folate status of nonpregnant women

Meta-analysis: Plant-based foods, fish serve up cognitive benefits for the Chinese

Meta-analysis: Plant-based foods, fish serve up cognitive benefits for the Chinese

Wearable red-light device looks good for poststroke rehabilitation

Wearable red-light device looks good for poststroke rehabilitation

Tavapadon shows promise as adjunct therapy for Parkinson’s Disease in phase III trial

Tavapadon shows promise as adjunct therapy for Parkinson’s Disease in phase III trial

Increased ischaemic stroke cases during Ramadan

Increased ischaemic stroke cases during Ramadan

CardiOmicScore: AI tool for personalized long-term CV risk prediction with enhanced accuracy

CardiOmicScore: AI tool for personalized long-term CV risk prediction with enhanced accuracy

Which strategy is best for treating hepatic encephalopathy in patients with dementia?

Which strategy is best for treating hepatic encephalopathy in patients with dementia?